Limited Efficacy of Cannabidiol on Adaptive Functioning in Boys with Profound Autism.
Oppenheim Hannah H, Umlauf Anya A, Grelotti David D, Grant Igor I et al.
This study examined the effect of cannabidiol (CBD) on adaptive functioning in boys with autism and severe cognitive and behavioral challenges using the Vineland Adaptive Behavior Scales, Third Edition (VABS-3). Primary outcome measures for a randomized, double-blind study of purified CBD and placebo are available online (Trauner et al., 2025). We now present results of a secondary outcome measure of adaptive functioning in a longitudinal design before and after treatment with CBD or placebo. Raw scores were analyzed after noting a floor effect of standard scores. No significant differences in adaptive functioning, except for motor skills, were found between CBD- and placebo-treated participants after 8 weeks of treatment. When compared to its immediate pre-treatment baseline, CBD (but not placebo) was associated with improvement in raw scores for Receptive and Written communication and showed near-significant improvement in Expressive Communication and Personal Skills. When compared to its immediate pre-treatment baseline, placebo was associated with improvement in Community and worsening of Motor Skills raw scores. There was a significant difference in standard and raw scores between CBD and placebo on the Motor Skills domain, with CBD treatment showing superiority to placebo. Although no significant between-group differences were found on most measures of adaptive functioning, within-group changes from zero to 8 weeks of treatment with CBD, but not placebo, showed improved communication skills in severely autistic boys. Future studies should account for placebo effects and severity of symptoms, include a larger sample size and individuals with a range of severity.